{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:35Z","timestamp":1792788575250,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["CSC 201909370087"],"award-info":[{"award-number":["CSC 201909370087"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.radonc.2023.109627","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T21:41:05Z","timestamp":1679089265000},"page":"109627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study"],"prefix":"10.1016","volume":"183","author":[{"given":"Haiyan","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizza E.L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J.A.","family":"Witlox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry J.M.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Praag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Belderbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Houben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"van der Noort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk K.M.","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109627_b0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1200\/JCO.21.01308","article-title":"Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"40","author":"Spigel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0010","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","article-title":"Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer","volume":"386","author":"Forde","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2023.109627_b0015","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S1470-2045(16)30065-1","article-title":"Prophylactic cranial irradiation for patients with lung cancer","volume":"17","author":"P\u00e9choux","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0020","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","article-title":"Small-cell lung cancer","volume":"378","author":"van Meerbeeck","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2023.109627_b0025","first-page":"50","article-title":"Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer","volume":"9","author":"Eggen","year":"2022","journal-title":"Neurooncol Pract"},{"key":"10.1016\/j.radonc.2023.109627_b0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ctrv.2016.03.009","article-title":"The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer","volume":"45","author":"Peters","year":"2016","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.109627_b0035","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/cam4.2958","article-title":"Patient reported symptoms associated with quality of life during chemo- or immunotherapy for bladder cancer patients with advanced disease","volume":"9","author":"Taarnh\u00f8j","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2023.109627_b0040","first-page":"3267","article-title":"Health-related quality of life, emotional burden, and neurocognitive function in the first generation of metastatic melanoma survivors treated with pembrolizumab: a longitudinal pilot study","volume":"28","author":"Rogiers","year":"2020","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2023.109627_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.685605","article-title":"Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients: the PRO-long study","volume":"11","author":"Van Der Weijst","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0050","unstructured":"Kanard A, Frytak S, Jatoi A. Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management. J Support Oncol. 2004;2:127-32; discussion 33-5, 38-40."},{"key":"10.1016\/j.radonc.2023.109627_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102025","article-title":"Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: a systematic review","volume":"88","author":"Zeng","year":"2020","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.109627_b0060","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2013.02.033","article-title":"Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214","volume":"86","author":"Gondi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109627_b0065","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1200\/JCO.2017.77.5817","article-title":"Prophylactic cranial irradiation versus observation in radically treated stage III non-small-cell lung cancer: a randomized phase III NVALT-11\/DLCRG-02 study","volume":"36","author":"De Ruysscher","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2023.109627_b0075","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, A B, et al. EORTC QLQ-C30 Scoring Manual (3rd edition). 3rd ed: Brussels: EORTC; 2001"},{"key":"10.1016\/j.radonc.2023.109627_b0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.2008.17.0746","volume":"27","author":"Slotman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2010.29.6053","article-title":"Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis","volume":"29","author":"Sun","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0090","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/annonc\/mdq576","article-title":"Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003\u201308004, RTOG 0212 and IFCT 99\u201301)","volume":"22","author":"Le Pechoux","year":"2011","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.radonc.2023.109627_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2022.106717","article-title":"Analyzing longitudinal binary data in clinical studies","volume":"115","author":"Li","year":"2022","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.radonc.2023.109627_b0105","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12874-019-0793-x","article-title":"Imputation strategies when a continuous outcome is to be dichotomized for responder analysis: a simulation study","volume":"19","author":"Floden","year":"2019","journal-title":"BMC Med Res Method"},{"key":"10.1016\/j.radonc.2023.109627_b0110","first-page":"4259205","article-title":"Neurotoxicity of tumor immunotherapy: the emergence of clinical attention","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0115","series-title":"Applied longitudinal data analysis for epidemiology : a practical guide","author":"Twisk","year":"2003"},{"key":"10.1016\/j.radonc.2023.109627_b0120","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1038\/s41598-022-14219-5","article-title":"The combined effect of physical activity and fruit and vegetable intake on decreasing cognitive decline in older Taiwanese adults","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2023.109627_b0125","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.770413","article-title":"Long-term cognitive dysfunction in cancer survivors","volume":"8","author":"Orsz\u00e1ghov\u00e1","year":"2021","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.radonc.2023.109627_b0130","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cam4.2069","article-title":"Cognitive complaints in cancer survivors and expectations for support: results from a web-based survey","volume":"8","author":"Lange","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.radonc.2023.109627_b0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2023.109627_b0140","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","article-title":"Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial","volume":"10","author":"Chang","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.annonc.2021.03.207","article-title":"Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2606)","volume":"32","author":"Dingemans","year":"2021","journal-title":"Ann Oncol : Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1037\/0022-006X.59.1.12","article-title":"Clinical significance: a statistical approach to defining meaningful change in psychotherapy research","volume":"59","author":"Jacobson","year":"1991","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.radonc.2023.109627_b0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2022.02.036","article-title":"Cost-effectiveness of prophylactic cranial irradiation in stage III non-small cell lung cancer","volume":"170","author":"Witlox","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0160","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1200\/JCO.21.00639","article-title":"Randomized phase III trial of prophylactic cranial irradiation with or without hippocampal avoidance for small-cell lung cancer (PREMER): a GICOR-GOECP-SEOR study","volume":"39","author":"Rodr\u00edguez de Dios","year":"2021","journal-title":"J Clin Oncol : Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0165","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/neuonc\/not114","article-title":"Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial","volume":"15","author":"Brown","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0170","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109627_b0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijrobp.2010.05.013","volume":"81","author":"Wolfson","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109627_b0180","unstructured":"Ruysscher DD, Hendriks L. Durvalumab and Low-dose PCI vs Durvalumab and Observation in Radically Treated Patients With Stage III NSCLC (NVALT28) 2022."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023001652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:28:11Z","timestamp":1759123691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023001652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":36,"alternative-id":["S0167814023001652"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109627","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for cognitive impairment in radically treated stage III NSCLC: Secondary findings of the NVALT-11 study","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109627"}}